GTC Biotherapeutics (fka GTCB)

[DragonBits]

BP, what makes you believe the value of GTC is unrecognized?

Abbott and Bristol-Myers Squibb have created founder animals, Genzyme is probably the most familiar with GTC, since these companies have worked with GTC they should be able to recognize the value of the company and buy it out or invest in it if they so desired. The fact that they haven't so far is one of the biggest negatives.

I have no idea how the market will react to FDA Atryn approval, and I am not sure that the FDA will approve Atryn without more data. EMEA was as close a call for approval we any company can have.

I am not sure if it has been discussed, does anyone know the sales of Atryn? The more it had been used in Europe with sucesss the easier it should be for the FDA to grant approval.

During the great depression many farmers were underfunded and overleveraged, they had to sell valuable farm land that 90 years later was worth 1000s of times more than what they were forced to sell at. So balance sheets and timing make a huge difference in ROI.

I was convinced 4 years ago that Transgenics worked as advertised, but I could also see that the biotech market place was never a believer in GTC's business plan. And I thought that GTC overstated the value of being able to produce already approved drugs via Transgenics.

I was trying to determine the future for GTC over the next year, so I thought it might be worthwhile discussing how much money GTC is expected to have in Oct 2009.